3 high-quality ASX 200 blue chip shares to buy this month

These blue chip shares have been given a big thumbs up from analysts.

| More on:
A young man goes over his finances and investment portfolio at home.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're looking to add some ASX 200 blue chip shares to your portfolio this month, then the three listed below could be worth considering.

These ASX 200 shares have all been named as buys recently. Here's what you need to know about them:

Cochlear Limited (ASX: COH)

The first ASX 200 blue-chip share that could be a buy this month is Cochlear.

It is a leading hearing solutions company with a portfolio of industry-leading cochlear implant devices under the Nucleus brand. The company also has its powerful Baha bone conduction hearing system.

Goldman Sachs is a fan of Cochlear and believes it is well-positioned for long-term growth. The broker has a buy rating and a $280 price target on its shares.

Goodman Group (ASX: GMG)

Another ASX 200 blue chip share that could be a buy is Goodman Group.

Goodman is one of the world's leading integrated commercial and industrial property companies. It has been growing at a solid rate for many years thanks to its world-class portfolio that gives it exposure to key growth markets such as e-commerce and logistics.

Citi is positive on the company and sees Goodman as a "beacon of growth in a sea of earnings declines." Its analysts are forecasting "a >12% EPS CAGR over FY24-FY26."

Citi has a buy rating on its shares with a $24.50 price target on its shares.

ResMed Inc. (ASX: RMD)

A final ASX 200 blue chip share that could be a buy is ResMed.

It is a sleep treatment-focused medical device company with a portfolio of leading hardware and digital solutions.

ResMed's shares have come under pressure recently due to the emergence of obesity drugs. However, Goldman Sachs isn't concerned and feels this has created a buying opportunity. Its analysts "believe a favourable risk-reward skew exists at the current share price."

Goldman has a buy rating and a $33 price target on the company's shares.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear, Goldman Sachs Group, Goodman Group, and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Cochlear and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has recommended Cochlear, Goodman Group, and ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

These ASX 200 shares could rise 30% to 50%

Brokers have good things to say about these cheap shares.

Read more »

Man jumps for joy in front of a background of a rising stocks graphic.
Share Market News

Record CBA share price and Iran-Israel ceasefire lift ASX 200 financials to new peak

ASX financial shares led the 11 market sectors last week, gaining 1.82% and reaching a record high.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Broker Notes

10 Aussie stocks to buy in FY 2026

Let's see which shares analysts think could be buys in the upcoming financial year.

Read more »

Person pretends to types on laptop drawn in sand.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing end to the trading week for investors this Friday.

Read more »

A young boy points and smiles as he eats fried chicken.
Share Gainers

3 ASX All Ords shares smashing the benchmark this week

Investors are sending these three ASX All Ords shares rocketing 18% to more than 29% this week. But why?

Read more »

watch
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why APA, Flight Centre, Reece, and Transurban shares are falling today

These shares are having a tough finish to the week. But why?

Read more »